Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Study

Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies

Summary

GBI Research has released its pharma research, "Ophthalmology Therapeutics in Major Developed Markets to 2019 - New Drug Approvals and Promising Pipeline to Trigger Shift in Treatment Paradigm to Combination Therapies", which provides insights into two therapeutic indications in ophthalmology in Top Eight Markets of the US, the UK, France, Germany, Italy, Spain, Japan and Canada. The report provides an in-depth analysis of the therapeutic indications of ophthalmology, namely glaucoma and Dry Eye Syndrome (DES). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these two ophthalmology indications.

Full Report Details at
- http://www.fastmr.com/prod/759215_ophthalmology_therapeutics_in_major_developed.aspx?afid=303

Scope

* Disease overview and treatment usage patterns
* Market size and forecast for glaucoma and DES in Top Eight Markets (the US, the UK, France, Germany, Italy, Spain, Japan and Canada) from 2012 to 2019
* Major marketed products for the indications types covered
* In-depth pipeline analysis for glaucoma and DES
* Key drivers and restraints that have had and are expected to have a significant impact upon the market
* Key licensing and co-development agreements in the ophthalmology market

Reasons to Get this Report

The report will enhance your decision-making capability by allowing you to -

* Align your product portfolio to the markets with high growth potential
* Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
* Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the ophthalmology market
* Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
* Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

You may also be interested in these related reports:

- Solid Tumors Market in Asia Pacific to 2019 - New Drug Approvals and Anticipated Product Launches to Trigger a Shift in Treatment Paradigm to Targeted Therapies
- Cardiovascular Diseases Therapeutics in Major Developed Markets to 2019 - Increasing Prevalence and Promising Novel Drugs offset Patent Cliff Threat
- Asthma Therapeutics Market to 2019 - Breakthrough Biologics to Enhance Treatment of Severe Asthma and Drive Market Growth
- Parkinson's Disease Therapeutics Market to 2019 - Pipeline Shows Shift Towards Long Term Disease Management
- Monoclonal Antibodies Market in Breast Cancer to 2019 - Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth